| |
| |
|
| Insider
Information: |
Lambert Nicole |
| Relationship: |
Director |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
239,593 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,928,423 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
239,593 |
|
|
| Total
Value |
$5,928,423 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Operating Officer |
2023-10-09 |
223,993 |
2019-09-25 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Director |
2023-06-15 |
15,600 |
2021-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2019-09-25 |
4 |
D |
$29.93 |
$37,981 |
D/D |
(1,269) |
24,686 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
64,686 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2019-09-30 |
4 |
D |
$28.63 |
$33,841 |
D/D |
(1,182) |
63,504 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-02-12 |
4 |
S |
$19.73 |
$85,915 |
D/D |
(4,354) |
59,150 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,646 |
66,796 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-09-25 |
4 |
D |
$12.44 |
$15,786 |
D/D |
(1,269) |
65,527 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-09-26 |
4 |
D |
$12.44 |
$36,511 |
D/D |
(2,935) |
62,592 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-09-30 |
4 |
D |
$13.04 |
$7,707 |
D/D |
(591) |
62,001 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, MGL |
• – – |
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
44,211 |
106,212 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
President, Myriad Oncology, |
• – – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
29,556 |
135,768 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-04-19 |
4 |
AS |
$27.01 |
$179,586 |
D/D |
(6,649) |
129,119 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
4,700 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-08-25 |
4 |
D |
$34.81 |
$39,092 |
D/D |
(1,123) |
127,996 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-08-27 |
4 |
AS |
$34.50 |
$32,603 |
D/D |
(945) |
127,051 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
65,870 |
192,921 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-09-25 |
4 |
D |
$33.31 |
$43,669 |
D/D |
(1,311) |
191,610 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-09-26 |
4 |
D |
$33.31 |
$114,120 |
D/D |
(3,426) |
188,184 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-09-27 |
4 |
AS |
$33.10 |
$334,747 |
D/D |
(10,112) |
178,072 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-10-01 |
4 |
AS |
$31.57 |
$44,835 |
D/D |
(1,420) |
176,652 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-10-09 |
4 |
D |
$30.88 |
$385,475 |
D/D |
(12,483) |
164,169 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
See Remarks |
• – – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
174,486 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
• – – |
2022-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
43,295 |
217,781 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
• – – |
2022-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
33,665 |
251,446 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Operating Officer |
• – – |
2022-03-24 |
4 |
D |
$25.32 |
$135,386 |
D/D |
(5,347) |
246,099 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,100 |
4,100 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
